Skip to search formSkip to main contentSkip to account menu

Bendroflumethiazide

Known as: Benzhydroflumethiazide, 6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide, Bendroflumetiazida 
A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Objective To determine whether combination of an angiotensin converting enzyme inhibitor with a high dose of thiazide diuretic… 
1998
1998
Objective To compare 2.5 mg bendrofluazide daily (the standard antihypertensive dose), 1.25 mg bendrofluazide daily and 2.5 mg… 
1992
1992
1. The common symptoms and signs of chronic heart failure are dyspnoea, ankle swelling, raised jugular venous pressure and basal… 
1984
1984
It has been postulated that depressed membrane sodium transport is a necessary step in blood pressure elevation in essential… 
1983
1983
A small double-blind pilot study was carried out to assess whether captopril treatment in hypertension has a euphoriant effect… 
1979
1979
1 Bendrofluazide (10 mg/day) or labetalol (300 mg and 600 mg/day) produced significant reductions in lying, standing, and post… 
1977
1977
Twenty-five patients with acute myeloid leukaemia were treated with three quadruple drug combinations in predetermined rotation… 
Highly Cited
1975
Highly Cited
1975
The effect of atenolol, a new beta-1-adrenergic receptor blocking agent, was studied in a double-blind cross-over trial in 24… 
1962
1962
Pilot studies with bendroflumethiazide, a recently introduced benzothiadiazine diuretic, 1,2 suggested superior antihypertensive…